Vanda Pharmaceuticals Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
199.45 |
224.88 |
310.10 |
404.25 |
534.00 |
604.00 |
| Przychód Δ r/r |
0.00% |
12.75% |
37.90% |
30.36% |
32.10% |
13.11% |
| Przychód (min) |
197.42 |
219.28 |
296.33 |
391.52 |
517.18 |
584.97 |
| Przychód (max) |
201.48 |
230.48 |
320.03 |
413.91 |
546.77 |
618.44 |
| EBITDA (średnia) |
4.15 |
4.68 |
6.45 |
8.41 |
11.11 |
12.56 |
| EBIT (średnia) |
0.58 |
0.66 |
0.90 |
1.18 |
1.56 |
1.76 |
| EBIT % |
0.29% |
0.29% |
0.29% |
0.29% |
0.29% |
0.29% |
| Zysk netto (średni) |
-16.98 |
-101.18 |
-63.60 |
-14.60 |
52.33 |
94.20 |
| Zysk netto % |
-8.51% |
-44.99% |
-20.51% |
-3.61% |
9.80% |
15.60% |
| EPS (średnia) |
-0.32 |
-1.74 |
-0.99 |
-0.23 |
0.90 |
1.62 |
| Liczba analityków (Przychody) |
2 |
2 |
3 |
2 |
1 |
1 |
| Liczba analityków (EPS) |
3 |
3 |
3 |
2 |
1 |
1 |
| symbol |
VNDA |
VNDA |
VNDA |
VNDA |
VNDA |
VNDA |